Concordantly, activation of the Nrf2 pathway by disrupting the Keap1/Nrf2 complex and enhancing the p47phox/Nrf2 complex might be a prospective approach for the prevention and treatment of diabetes-associated complications, such as atherosclerosis. This evidence concerns the gene NCF1 and diabetes mellitus.